In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s00280-014-2533-6
Published Online: 2014-07-20
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Radujkovic, Aleksandar
Luft, Thomas
Dreger, Peter
Ho, Anthony D.
Jens Zeller, W.
Fruehauf, Stefan
Topaly, Julian
Text and Data Mining valid from 2014-07-20